Previous studies confirmed that regulating aerobic glycolysis is an important factor for Sishen Pill to treat colon cancer (Zhang et al., 2021d; Jiang et al., 2023); whether it is related to HIF-1α remains to be determined. The gene discussed is HIF1A; the disease is malignant colon neoplasm.